Treatment-induced EMT reduces GATA6<sup>+</sup> populations and MHCI expression, which is restored by combining MEKi with HDAC inhibitors, enhancing GATA6<sup>+</sup> tumor cells, MHCI, CD8<sup>+</sup> T cell infiltration, tumor suppression, and survival. Here, HDAC9 is linked to neoplasm.